M&A, Medical device

BTG acquires emphysema innovator PneumRx

Posted on 05 December 2014

Tags: ,

Forbion Capital Partners announced the sale of its portfolio company PneumRx to BTG for an initial cash consideration of USD 230M (EUR 186M) and up to USD 245M (EUR 199M) in performance-related future milestone payments.

For further deal information visit Current Agreements (subscription required)

Related

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

Report: Top 50 Big Biotech Partnering and M&A Deal Trends

Browse: Complete Current Partnering report catalog

Print Friendly, PDF & Email

Leave a Reply